Hospital
North Broward Hospital District
North Broward Hospital District was paid $18.48M by Medicaid between Jan 2018 and Dec 2024, across 199 billing codes. Its largest line is 99283, emergency room visit (moderate) — 24% of everything it billed.
33Billing provider infoNORTH BROWARD HOSPITAL DISTRICT
CORAL SPRINGS, FL 33065
CORAL SPRINGS, FL 33065
33aNPI1174551147assigned 06/29/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$18.48M
24GClaims629,714
24DCodes billed199
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Florida
Rank by total paid#20 of 163
Median peer was paid$4.77M
This provider vs. median3.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official BERT, ALISA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 31,206 | $666K | |
| 2019 | 129,763 | $2.56M | |
| 2020 | 81,287 | $1.51M | |
| 2021 | 117,737 | $3.12M | |
| 2022 | 141,620 | $5.20M | |
| 2023 | 89,282 | $3.65M | |
| 2024incomplete | 38,819 | $1.76M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 24% | 47,854 | 44,694 | $4.44M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 18% | 32,943 | 29,442 | $3.30M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 5.2% | 11,517 | 3,228 | $956K |
| 59899 | 4.9% | 4,555 | 3,378 | $914K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 4.5% | 11,130 | 3,299 | $827K |
| 70450 | Computed tomography, head or brain; without contrast material | 4.2% | 4,882 | 4,346 | $785K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.1% | 9,160 | 7,795 | $762K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 4.1% | 10,539 | 2,948 | $754K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.6% | 8,161 | 7,640 | $662K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.2% | 2,947 | 2,600 | $598K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.6% | 8,369 | 7,414 | $481K |
| 87631 | 2.1% | 2,959 | 2,863 | $386K |
187 more codes
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.5% | 1,463 | $269K |
| G0378 | Hospital observation service, per hour | 1.3% | 11,483 | $240K |
| 36415 | Collection of venous blood by venipuncture | 1.2% | 33,816 | $226K |
| E0700 | Safety equipment, device or accessory, any type | 1.2% | 615 | $217K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 1.1% | 3,904 | $206K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 4,207 | $159K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 713 | $134K |
| 80053 | Comprehensive metabolic panel | <1% | 27,785 | $119K |
| 87070 | <1% | 8,141 | $108K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 11,852 | $88K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 15,969 | $85K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,173 | $84K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 7,056 | $82K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 397 | $79K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 13,782 | $78K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,849 | $75K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,316 | $63K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 2,512 | $62K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 1,600 | $62K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 13,957 | $60K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 628 | $60K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 10,421 | $48K |
| 81001 | <1% | 22,250 | $47K | |
| 76775 | <1% | 791 | $44K | |
| 87486 | <1% | 1,632 | $39K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 932 | $38K |
| 97161 | <1% | 627 | $38K | |
| 74018 | <1% | 3,708 | $34K | |
| 76801 | <1% | 2,174 | $31K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 20,683 | $30K |
| 76830 | Ultrasound, transvaginal | <1% | 1,046 | $29K |
| 12011 | <1% | 397 | $29K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 1,393 | $29K |
| 76641 | <1% | 447 | $29K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 40,413 | $28K |
| 81003 | <1% | 3,320 | $26K | |
| 71045 | Radiologic examination, chest; single view | <1% | 7,838 | $26K |
| 76818 | <1% | 1,268 | $25K | |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 47 | $23K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 429 | $21K |
| 73564 | <1% | 800 | $18K | |
| 93976 | <1% | 918 | $17K | |
| 87420 | <1% | 2,282 | $17K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 868 | $16K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 179 | $15K |
| 73610 | <1% | 904 | $14K | |
| 73630 | <1% | 1,206 | $13K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 10,169 | $12K |
| 87507 | <1% | 74 | $12K | |
| 81025 | <1% | 3,227 | $12K | |
| 12001 | <1% | 162 | $12K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 1,291 | $11K |
| 73130 | <1% | 592 | $10K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 9,633 | $10K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 522 | $10K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 810 | $10K |
| 70486 | <1% | 83 | $10K | |
| 95819 | <1% | 106 | $9K | |
| 84702 | <1% | 3,810 | $9K | |
| 87077 | <1% | 1,369 | $8K | |
| 93971 | <1% | 489 | $8K | |
| 87040 | <1% | 8,729 | $8K | |
| 84484 | <1% | 6,117 | $8K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 146 | $8K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 111 | $7K |
| 97165 | <1% | 59 | $7K | |
| 73030 | <1% | 611 | $7K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 5,014 | $7K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 6,705 | $6K |
| 73110 | <1% | 513 | $6K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 8,113 | $6K |
| 87430 | <1% | 8,112 | $5K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 609 | $5K |
| 85610 | <1% | 4,265 | $5K | |
| 86850 | <1% | 1,424 | $5K | |
| 87210 | <1% | 684 | $4K | |
| 72100 | <1% | 650 | $4K | |
| 80061 | Lipid panel | <1% | 1,418 | $4K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 1,507 | $4K |
| 83605 | <1% | 2,696 | $4K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 14 | $4K |
| 83735 | <1% | 3,279 | $4K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,237 | $4K |
| 83690 | <1% | 7,883 | $3K | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,857 | $3K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 507 | $3K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,751 | $3K |
| 76536 | <1% | 45 | $3K | |
| 86900 | <1% | 3,170 | $3K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 840 | $3K |
| 72131 | <1% | 41 | $3K | |
| 85730 | <1% | 3,463 | $3K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 6,604 | $2K |
| 80076 | <1% | 1,535 | $2K | |
| 92523 | <1% | 14 | $2K | |
| 86901 | <1% | 3,173 | $2K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 1,224 | $2K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 191 | $2K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 243 | $2K |
| 84703 | <1% | 7,216 | $2K | |
| 93970 | <1% | 36 | $2K | |
| 59025 | Fetal non-stress test | <1% | 14 | $1K |
| 87045 | <1% | 191 | $1K | |
| 97162 | <1% | 19 | $1K | |
| 83880 | <1% | 1,355 | $1K | |
| 73560 | <1% | 41 | $991.96 | |
| 86140 | <1% | 8,754 | $979.01 | |
| 70491 | <1% | 12 | $937.66 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,780 | $920.18 |
| 73090 | <1% | 105 | $879.51 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 317 | $867.29 |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 865 | $824.21 |
| 82728 | <1% | 127 | $734.91 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 802 | $691.00 |
| 73070 | <1% | 31 | $689.48 | |
| 73140 | <1% | 172 | $688.24 | |
| 73590 | <1% | 105 | $610.41 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 371 | $600.81 |
| 87186 | <1% | 1,988 | $542.06 | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 15 | $537.47 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 1,955 | $512.96 |
| 85379 | <1% | 1,260 | $487.68 | |
| 93975 | <1% | 45 | $472.12 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 1,014 | $425.49 |
| A9270 | Non-covered item or service | <1% | 1,082 | $420.98 |
| 72040 | <1% | 85 | $393.78 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 82 | $388.24 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 181 | $338.46 |
| 82550 | <1% | 2,163 | $327.03 | |
| 87581 | <1% | 1,632 | $325.53 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 313 | $311.80 |
| 95957 | <1% | 71 | $293.11 | |
| J7510 | Prednisolone oral, per 5 mg | <1% | 2,861 | $288.95 |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 1,095 | $287.08 |
| 87205 | <1% | 266 | $282.55 | |
| 87088 | <1% | 1,299 | $274.96 | |
| 82150 | <1% | 1,141 | $184.92 | |
| 29125 | <1% | 76 | $169.38 | |
| 76870 | <1% | 30 | $148.27 | |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 297 | $126.86 |
| 70360 | <1% | 14 | $95.91 | |
| 84550 | <1% | 135 | $86.83 | |
| 85651 | <1% | 825 | $83.54 | |
| 96376 | <1% | 617 | $67.16 | |
| 84100 | <1% | 475 | $63.01 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,592 | $62.30 |
| 82746 | <1% | 13 | $46.29 | |
| 73080 | <1% | 43 | $38.61 | |
| 74019 | <1% | 17 | $35.85 | |
| 74022 | <1% | 16 | $35.85 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 500 | $25.99 |
| 86308 | <1% | 178 | $25.06 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 750 | $18.16 |
| 87046 | <1% | 214 | $17.42 | |
| 73502 | <1% | 14 | $15.71 | |
| 84439 | <1% | 33 | $14.29 | |
| 83615 | <1% | 262 | $10.94 | |
| 87147 | <1% | 121 | $10.78 | |
| J3490 | Unclassified drugs | <1% | 258 | $6.79 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 104 | $5.04 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 56 | $4.90 |
| 82553 | <1% | 73 | $4.90 | |
| 83540 | <1% | 14 | $4.72 | |
| 85046 | <1% | 36 | $2.94 | |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | <1% | 35 | $0.98 |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 1,436 | $0.98 |
| 88312 | <1% | 16 | $0.76 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 0% | 2,369 | $0.00 |
| 36600 | 0% | 12 | $0.00 | |
| 94667 | 0% | 22 | $0.00 | |
| 85384 | 0% | 48 | $0.00 | |
| 90715 | 0% | 27 | $0.00 | |
| 29515 | 0% | 27 | $0.00 | |
| A4614 | Peak expiratory flow rate meter, hand held | 0% | 22 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 54 | $0.00 |
| 85007 | 0% | 12 | $0.00 | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 0% | 229 | $0.00 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 0% | 32 | $0.00 |
| J8597 | Antiemetic drug, oral, not otherwise specified | 0% | 301 | $0.00 |
| 82803 | 0% | 12 | $0.00 | |
| 85027 | 0% | 24 | $0.00 | |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | 0% | 46 | $0.00 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 0% | 177 | $0.00 |
| J1741 | Injection, ibuprofen, 100 mg | 0% | 17 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 30 | $0.00 |
| 87425 | 0% | 29 | $0.00 | |
| 82607 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBERT, ALISA (INTERIM CFO)
Parent organizationNORTH BROWARD HOSPITAL DISTRICT
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.